The investment case for Zhejiang Huahai, based within the province of Zhejiang, is that it is cheap based on current ...

“We thank our stockholders for their support through our time as a public company and the duration of this process,” said Nick Green, president and CEO of Avid Bioservices. “We look forward to ...

Avid Bioservices ( ($CDMO) ) has provided an update. On January 30, 2025, Avid Bioservices held a special meeting of stockholders where they ...

Alzheimer’s Therapeutics MarketThe global Alzheimer’s therapeutics market is projected to experience significant growth, with an expected valuation of USD 3,052.3 million in 2023. The market is ...

Detailed price information for Red Light Holland Corp (TRIP-CN) from The Globe and Mail including charting and trades.

Building on the momentum achieved so far, the company's management expects SRF to finish the year on a reasonably strong ...

VMD response to concerns raised following media reports of serious adverse events in cats administered Solensia. The VMD is aware of media reports and ...

Takeda has announced the appointment of Julie Kim as the successor to Christophe Weber, effective from June 2026.

The pathway allows medicine developers to work with the regulators, the NHS and health technology assessment bodies.

Shionogi’s oral antiviral for respiratory syncytial virus (RSV) has met its primary endpoint in a Phase II study.

The 2-acetylthiophene market is expected to achieve a valuation of USD 150 billion by 2033, growing at a CAGR of 5.2% from 2023. Pharmaceutical and agrochemical sectors remain the largest consumers, ...

Andrew Pierce, senior executive at French biotech Owkin, on how artificial intelligence can make the drug development process more efficient.